Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600200 from our risk checks.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥9.00 |
52 Week High | CN¥13.88 |
52 Week Low | CN¥6.90 |
Beta | 0.12 |
11 Month Change | -2.39% |
3 Month Change | -17.88% |
1 Year Change | 19.05% |
33 Year Change | 12.50% |
5 Year Change | 84.80% |
Change since IPO | 60.72% |
Recent News & Updates
Sentiment Still Eluding JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Jul 31JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt
Jun 06Recent updates
Shareholder Returns
600200 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 11.5% | 2.5% | 3.3% |
1Y | 19.0% | -12.2% | -19.1% |
Return vs Industry: 600200 exceeded the CN Pharmaceuticals industry which returned -17.3% over the past year.
Return vs Market: 600200 exceeded the CN Market which returned -21.8% over the past year.
Price Volatility
600200 volatility | |
---|---|
600200 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 600200's share price has been volatile over the past 3 months.
Volatility Over Time: 600200's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 1,050 | Qunshan Qian | www.600200.com |
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Fundamentals Summary
600200 fundamental statistics | |
---|---|
Market cap | CN¥6.34b |
Earnings (TTM) | -CN¥95.04m |
Revenue (TTM) | CN¥2.33b |
2.7x
P/S Ratio-66.7x
P/E RatioIs 600200 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600200 income statement (TTM) | |
---|---|
Revenue | CN¥2.33b |
Cost of Revenue | CN¥1.80b |
Gross Profit | CN¥535.31m |
Other Expenses | CN¥630.35m |
Earnings | -CN¥95.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
Earnings per share (EPS) | -0.13 |
Gross Margin | 22.96% |
Net Profit Margin | -4.08% |
Debt/Equity Ratio | 101.8% |
How did 600200 perform over the long term?
See historical performance and comparison